Literature DB >> 31567446

Antepartum and intrapartum risk factors for neonatal hypoxic-ischemic encephalopathy: a systematic review with meta-analysis.

A Cristina Rossi1, Federico Prefumo2.   

Abstract

PURPOSE OF REVIEW: To review literature about risk factors of neonatal hypoxic-ischemic encephalopathy (HIE). RECENT
FINDINGS: Search in PubMed, MEDLINE, Embase, Clinicaltrials.gov and reference lists from 1999 to 2018. INCLUSION CRITERIA: study population composed of neonates who manifested HIE within 28 days from delivery, data reported as proportional rate. Studies were excluded if they included preterm pregnancies, postnatal conditions leading to HIE and/or fetal malformations, focused on a single risk factor, were not in English language. PRISMA guidelines were followed. Interstudies heterogeneity was assessed and a random/fixed models were generated as appropriate. Comparison between neonates with HIE vs. controls was performed by calculating odds ratio-95% confidence interval (OR-95% CI). Differences were significant if 95% CI did not encompass 1. Twelve articles were included. Fetuses with growth restriction (OR: 2.87; 95% CI: 1.77-4.67), nonreassuring cardiotocography (OR: 6.38; 95% CI: 2.56-15.93), emergency cesarean section (OR: 3.69; 95% CI: 2.75-4.96), meconium (OR: 3.76; 95% CI: 2.58-5.46) and chorioamnionitis (OR: 3.46: 95% CI: 2.07-5.79) were at higher risk of developing HIE. Nulliparity, gestational diabetes, hypertension, oligohydramnios, polyhydramnios, male sex, induction of labor, labor augmentation, premature rupture of membrane, and vacuum delivery were not significantly different.
SUMMARY: Neonatal HIE has multifactorial origin and its cause is often undetermined and not preventable.PROSPERO (Registration number: CRD42018106563).

Entities:  

Year:  2019        PMID: 31567446     DOI: 10.1097/GCO.0000000000000581

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  5 in total

Review 1.  Neuroprotective therapies in the NICU in term infants: present and future.

Authors:  Eleanor J Molloy; Mohamed El-Dib; Sandra E Juul; Manon Benders; Fernando Gonzalez; Cynthia Bearer; Yvonne W Wu; Nicola J Robertson; Tim Hurley; Aoife Branagan; C Michael Cotten; Sidhartha Tan; Abbot Laptook; Topun Austin; Khorshid Mohammad; Elizabeth Rogers; Karen Luyt; Sonia Bonifacio; Janet S Soul; Alistair J Gunn
Journal:  Pediatr Res       Date:  2022-10-04       Impact factor: 3.953

2.  Is meconium exposure associated with autism spectrum disorders in children?

Authors:  Ensiyeh Jenabi; Erfan Ayubi; Salman Khazaei; Saeid Bashirian; Mojtaba Khazaei
Journal:  Clin Exp Pediatr       Date:  2020-10-04

3.  Therapeutic Hypothermia Modulates the Relationships Between Indicators of Severity of Neonatal Hypoxic Ischemic Encephalopathy and Serum Biomarkers.

Authors:  Raul Chavez-Valdez; Sarah Miller; Harisa Spahic; Dhananjay Vaidya; Charlamaine Parkinson; Barbara Dietrick; Sandra Brooks; Gwendolyn J Gerner; Aylin Tekes; Ernest M Graham; Frances J Northington; Allen D Everett
Journal:  Front Neurol       Date:  2021-11-02       Impact factor: 4.086

Review 4.  Changing Perspectives of Electronic Fetal Monitoring.

Authors:  Mark I Evans; David W Britt; Shara M Evans; Lawrence D Devoe
Journal:  Reprod Sci       Date:  2021-10-18       Impact factor: 2.924

Review 5.  Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action.

Authors:  Vaisakh Krishnan; Vijay Kumar; Gabriel Fernando Todeschi Variane; Waldemar A Carlo; Zulfiqar A Bhutta; Stéphane Sizonenko; Anne Hansen; Seetha Shankaran; Sudhin Thayyil
Journal:  Semin Fetal Neonatal Med       Date:  2021-07-24       Impact factor: 3.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.